Skip to content

Fabrizio Schifano

University of Hertfordshire

59 papers in the library · 3,057 citations · publishing 2000-2026

Papers

Sort Most recent Most cited

Near-Death States Reported in a Sample of 50 Misusers

Substance Use & Misuse March 1, 2010 Ornella Corazza, Fabrizio Schifano 43 citations

Increase in recreational ketamine use may be a cause for concern. We aimed here at assessing, in a sample of ketamine misusers, concordance between the typical near-death experience (NDE) features and the on-drug psychoactive effects the subjects experienced. In 2003-2005, a sample of previous ketamine misusers recollecting a ketamine-related NDE were recruited through snowballing and screened...

Psychoactive drug or mystical incense? Overview of the online available information on Spice products

International Journal of Culture and Mental Health December 1, 2009 Fabrizio Schifano, Ornella Corazza, Paolo Deluca et al. 79 citations

The aim of the study was to foster the collection and analysis of data from web pages related to information on the consumption, manufacture and sale of Spice products, a brand name for an herbal smoking blend, sold as legal substitute for cannabis. The Google search engine was used to carry out an 8-language qualitative assessment of information available on Spice products in a sample of about...

[Salvia divinorum--representation of a new drug in the Internet].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) May 1, 2006 Holger Siemann, Michael Specka, Fabrizio Schifano et al. 10 citations

The German pages of the Internet were searched for the presence of the hallucinogenic herbal drug Salvia divinorum, which is not dealt with in current addiction medicine or psychiatric text books. The investigation is part of the EU sponsored project "Psychonaut" as preparatory work for the development of an Internet-based early warning system. The first 100 websites of the search using "Salvia...

Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994–2003)

Journal of Psychopharmacology March 30, 2006 Fabrizio Schifano, John Corkery, Paolo Deluca et al. 96 citations

In the last decade, a global trend of escalating ecstasy (MDMA, MDA, MDEA, MBDB) use was observed. Mentions on medical death certificates, last year's ecstasy use, number of drug offenders, seizures, prices and dosage levels figures were used for this descriptive and correlational study. Figures (1994ñ2003) were taken from the UK General Mortality Registers, from the Home Office Statistical...

Psychedelics in psychiatry

The British Journal of Psychiatry December 30, 2005 Danilo Arnone, Fabrizio Schifano 2 citations

It is likely therefore that cognitive impair-It is likely therefore that cognitive impairment was present in many.Hence the ment was present in many.Hence the 'personality subtypes' identified may vanish 'personality subtypes' identified may vanish on refeeding, or may be more pronounced, on refeeding, or may be more pronounced, having been masked by cognitive blunting.having been masked by...

New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').

Journal of psychopharmacology (Oxford, England) November 1, 2005 Fabrizio Schifano, Paolo Deluca, Lisa Agosti et al. 70 citations

2C-T-7 ('Blue Mystic'), an illicit compound which shows similarities with MDMA and other designer drugs, has been only occasionally identified in the EU, but discussion on the Internet between experimenters has recently grown significantly. We aimed at collecting together in a review the available information on 2C-T-7, both at the cyber and at the street market level. 2C-T-7 was first...

A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities.

Psychopharmacology May 2004 Fabrizio Schifano

The issue of ecstasy-related fatalities has extensively attracted the attention of both the media and the general public, but less so of the scientific literature. The aim of the present review is to focus on the epidemiological, clinical and pharmacological issues related to ecstasy fatalities. Possibly due to a number of different reasons, the rates of ecstasy-related deaths seem to have...

Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002

Human Psychopharmacology Clinical and Experimental September 19, 2003 Fabrizio Schifano, Adenekan Oyefeso, John Corkery et al. 93 citations

Abstract The present study reports on all deaths related to taking ecstasy (alone, or in a polydrug combination) occurring in England and Wales in the time frame August 1996–April 2002. Data presented here are based on all information recorded in the National Programme on Substance Abuse Deaths (np‐SAD) database. The np‐SAD regularly receives all information on drug related deaths in addicts...

Potential Human Neurotoxicity of MDMA (‘Ecstasy’): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies

Neuropsychobiology 2000 Fabrizio Schifano 83 citations

The present paper attempts to give an updated overview of the magnitude of the phenomenon of ecstasy abuse in Italy and other European countries. It gives an account of some clinical case studies and of a larger-scale report on polydrug (including MDMA) consumers attending our Public Health Addiction Treatment Unit in recent years, with a view to clarifying the characteristics and...